296 related articles for article (PubMed ID: 30760164)
41. Bing-Neel syndrome: a rare complication of Waldenström macroglobulinemia.
Sánchez-Guerrero S; Castillo JJ
Blood; 2015 Sep; 126(11):1390. PubMed ID: 26605390
[No Abstract] [Full Text] [Related]
42. Mixed Diffuse and Tumoral Form of Bing-Neel Syndrome Successfully Treated with Ibrutinib.
Naveed Ahmad JA; Schroeder BA; Yun JPT; Aboulafia DM
Case Rep Oncol; 2023; 16(1):1353-1361. PubMed ID: 37946745
[TBL] [Abstract][Full Text] [Related]
43. Bing-Neel syndrome revealing Waldenström's macroglobulinemia: a case report.
Jennane S; El Maaroufi H; Mahtat EM; Mikdame M; Doghmi K
Tunis Med; 2020 Oct; 98(10):750-753. PubMed ID: 33479948
[TBL] [Abstract][Full Text] [Related]
44. [Complete response with tirabrutinib for relapsed and refractory Bing-Neel syndrome].
Hagihara M; Ide S; Ohara S; Imai Y; Uchida T; Inoue M
Rinsho Ketsueki; 2022; 63(7):770-775. PubMed ID: 35922946
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement.
Hiemcke-Jiwa LS; Leguit RJ; Radersma-van Loon JH; Westerweel PE; Rood JJM; Doorduijn JK; Huibers MMH; Minnema MC
Leuk Lymphoma; 2018 May; 59(5):1256-1259. PubMed ID: 28849690
[No Abstract] [Full Text] [Related]
46. Sudden ventricular fibrillation and death during ibrutinib therapy-A case report.
Bernardeschi P; Pirrotta MT; Del Rosso A; Fontanelli G; Milandri C
Eur J Haematol; 2019 Oct; 103(4):442-443. PubMed ID: 31287200
[TBL] [Abstract][Full Text] [Related]
47. Diagnosing, imaging, and successfully treating a debilitating case of Bing-Neel syndrome: A multidisciplinary feat.
Kerley RN; O'Donnell N; Lynott F; Mulcahy R; Hennessy B
Clin Case Rep; 2023 May; 11(5):e7296. PubMed ID: 37151950
[TBL] [Abstract][Full Text] [Related]
48. Bing-Neel syndrome presenting with bilateral lumbar radiculopathy: A case report of a rare clinical entity.
Brotis AG; Palassopoulou M; Kapsalaki EZ; Paschalis T; Papastergiou V; Fountas KN
Neurocirugia (Astur : Engl Ed); 2021 May; ():. PubMed ID: 34045126
[TBL] [Abstract][Full Text] [Related]
49. Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review.
Moore DC
J Oncol Pharm Pract; 2021 Dec; 27(8):1993-1999. PubMed ID: 34558376
[TBL] [Abstract][Full Text] [Related]
50. ibrutinib (IMBRUVICA°) and Waldenström's macroglobulinaemia.
Prescrire Int; 2016 Oct; 25(175):232. PubMed ID: 30645823
[TBL] [Abstract][Full Text] [Related]
51. Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.
Gustine JN; Meid K; Dubeau T; Severns P; Hunter ZR; Guang Y; Xu L; Treon SP; Castillo JJ
Am J Hematol; 2018 Aug; 93(4):511-517. PubMed ID: 29280186
[TBL] [Abstract][Full Text] [Related]
52. Beyond monoclonal gammopathy of undetermined significance, clinical spectrum of immunoglobulin M gammopathy: a case series with focus on the diagnostic and management challenges.
Ashruf OS; Mirzai S; George LL; Anwer F
Int J Hematol Oncol; 2023 Jun; 12(2):IJH44. PubMed ID: 37304326
[TBL] [Abstract][Full Text] [Related]
53. Monitoring of MYD88 L265P mutation by droplet digital polymerase chain reaction for prediction of early relapse in a patient with Bing-Neel syndrome.
Shikata H; Kihara H; Kaneko M; Matsukage S; Hattori K
Int J Hematol; 2021 Apr; 113(4):586-591. PubMed ID: 33222046
[TBL] [Abstract][Full Text] [Related]
54. Bing-Neel syndrome: a rare neurological complication of Waldenström macroglobulinaemia.
Alzghoul H; Haider A; Mukhtar F; Khuddus N
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38182164
[TBL] [Abstract][Full Text] [Related]
55. Ibrutinib-induced acute liver failure.
Kahn A; Horsley-Silva JL; Lam-Himlin DM; Reeder CB; Douglas DD; Carey EJ
Leuk Lymphoma; 2018 Feb; 59(2):512-514. PubMed ID: 28693376
[No Abstract] [Full Text] [Related]
56. Successful Treatment of Bing-Neel Syndrome Accompanying Waldenström's Macroglobulinemia with R-MPV: A Case Report.
Kikukawa Y; Yamamura-Fujimoto A; Endo S; Miyagawa E; Kawano Y; Ueno S; Mitsuya H; Hata H; Okuno Y
J Clin Exp Hematop; 2015; 55(2):113-9. PubMed ID: 26490525
[TBL] [Abstract][Full Text] [Related]
57. Primary central nervous system diffuse large B-cell lymphoma masqueraded as Bing-Neel syndrome: Steps in management and review of future directions.
Delasos L; Phachu D; Shetty N; Sepulveda-Ramos M; Vredenburgh J
Clin Case Rep; 2021 Dec; 9(12):e05113. PubMed ID: 34925831
[TBL] [Abstract][Full Text] [Related]
58. Intracranial venous sinus thrombosis as unusual presentation of Bing-Neel syndrome: case illustration.
Morabito R; Grasso G; Barresi V; La Spina P; Garufi G; Alafaci E; Salpietro FM; Longo M; Granata F; Alafaci C
J Neurosurg; 2017 Nov; 127(5):1084-1085. PubMed ID: 27911232
[No Abstract] [Full Text] [Related]
59. [Ibrutinib prescription in B-cell lymphoid neoplasms].
Dougé A; Ravinet A; Bay JO; Tournilhac O; Guièze R; Lemal R
Bull Cancer; 2016 Feb; 103(2):127-37. PubMed ID: 26822906
[TBL] [Abstract][Full Text] [Related]
60. Analysis of Efficacy and Tolerability of Bruton Tyrosine Kinase Inhibitor Ibrutinib in Various B-cell Malignancies in the General Community: A Single-center Experience.
Ali N; Malik F; Jafri SIM; Naglak M; Sundermeyer M; Pickens PV
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S53-S61. PubMed ID: 28760303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
